High expression of both PD-L1 and CTLA-4 can inhibit the activity of T cells, which may lead to a lack of immune response in cancer patients, resulting in immune evasion of cancer cells and promoting cancer cell proliferation. This evidence concerns the gene CTLA4 and cancer.